Posttransplant lymphoproliferative disease and survival in adult heart transplant recipients

被引:5
作者
Hayes, Don, Jr. [1 ,2 ,3 ,4 ,5 ,6 ]
Tumin, Dmitry [1 ,5 ,7 ]
Foraker, Randi E. [4 ,5 ]
Tobias, Joseph D. [5 ,7 ,8 ]
机构
[1] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA
[2] Ohio State Univ, Coll Med, Dept Internal Med, Columbus, OH 43210 USA
[3] Ohio State Univ, Coll Med, Dept Surg, Columbus, OH 43210 USA
[4] Ohio State Univ, Coll Publ Hlth, Div Epidemiol, Columbus, OH 43210 USA
[5] Nationwide Childrens Hosp, Ctr Epidemiol Study Organ Failure & Transplantat, Columbus, OH USA
[6] Nationwide Childrens Hosp, Sect Pulm Med, Columbus, OH USA
[7] Nationwide Childrens Hosp, Dept Anesthesiol & Pain Med, Columbus, OH USA
[8] Ohio State Univ, Coll Med, Dept Anesthesiol, Columbus, OH 43210 USA
关键词
Adult; Heart transplantation; Posttransplant lymphoproliferative disease; Survival; EPSTEIN-BARR-VIRUS; SINGLE-CENTER; DISORDER; RISK; EBV; REGISTRY;
D O I
10.1016/j.jjcc.2016.02.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The influence of posttransplant lymphoproliferative disease (PTLD) on long-term survival after heart transplantation (HTx) in adult recipients needs better characterization. Methods: The United Network for Organ Sharing database was queried from 2006 to 2015 to compare survival between adult HTx recipients with and without PTLD. Cox proportional hazards models were used to analyze the primary outcome of survival, and competing-risks regression was used to analyze the outcome of PTLD development. Results: A total of 14,487 HTx recipients who had data on PTLD were included in univariate Cox analysis and Kaplan-Meier survival function, while 10,422 were included in multivariable Cox analysis and 162 selected for a matched-pairs sample after matching on the propensity of developing PTLD. The cohort included 120 patients who were diagnosed with PTLD. Onset of PTLD, treated as a time-varying covariate, was adversely associated with survival in univariate (HR = 4.953; 95% CI: 3.768, 6.511; p < 0.001) and multivariable (HR = 3.849; 95% CI: 2.669, 5.552; p < 0.001) Cox proportional hazards models. Cox regression stratified on matched pairs of PTLD cases and non-PTLD controls confirmed the risk for death associated with PTLD onset (HR = 2.667; 95% CI: 1.043, 6.815; p = 0.040). Conclusions: PTLD onset negatively influenced survival in adult HTx recipients, whereas no characteristics predisposing patients to PTLD development were identified in multivariate analysis. (C) 2016 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:144 / 148
页数:5
相关论文
共 17 条
[1]   Post-transplantation lymphoproliferative disorder in the Epstein-Barr virus-naive lung transplant recipient [J].
Aris, RM ;
Maia, DM ;
Neuringer, IP ;
Gott, K ;
Kiley, S ;
Gertis, K ;
Handy, J .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 154 (06) :1712-1717
[2]   Post-transplant lymphoproliferative disorders after heart or kidney transplantation at a single centre: Presentation and response to treatment [J].
Aversa, S. M. L. ;
Stragliotto, S. ;
Marino, D. ;
Calabrese, F. ;
Rigotti, P. ;
Marchini, F. ;
Gambino, A. ;
Feltrin, G. ;
Boso, C. ;
Canova, F. ;
Solda, C. ;
Mazzarotto, R. ;
Burra, P. .
ACTA HAEMATOLOGICA, 2008, 120 (01) :36-46
[3]   A 16-Year Multi-Institutional Study of the Role of Age and EBV Status on PTLD Incidence Among Pediatric Heart Transplant Recipients [J].
Chinnock, R. ;
Webber, S. A. ;
Dipchand, A. I. ;
Brown, R. N. ;
George, J. F. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (11) :3061-3068
[4]   Malignancy after heart transplantation:: Incidence, prognosis and risk factors [J].
Crespo-Leiro, M. G. ;
Alonso-Pulpon, L. ;
de Prada, J. A. Vazquez ;
Almenar, L. ;
Arizon, J. M. ;
Brossa, V. ;
Delgado, J. F. ;
Fernandez-Yanez, J. ;
Manito, N. ;
Rabago, G. ;
Lage, E. ;
Roig, E. ;
Diaz-Molina, B. ;
Pascual, D. ;
Muniz, J. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 (05) :1031-1039
[5]   Associations Between EBV Serostatus and Organ Transplant Type in PTLD Risk: An Analysis of the SRTR National Registry Data in the United States [J].
Dharnidharka, V. R. ;
Lamb, K. E. ;
Gregg, J. A. ;
Meier-Kriesche, H. -U. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (04) :976-983
[6]   Post-transplant lymphoproliferative disease [J].
Dharnidharka, Vikas R. ;
Araya, Carlos E. .
PEDIATRIC NEPHROLOGY, 2009, 24 (04) :731-736
[7]   A proportional hazards model for the subdistribution of a competing risk [J].
Fine, JP ;
Gray, RJ .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1999, 94 (446) :496-509
[8]   Transmission of donor Epstein-Barr virus (EBV) in transplanted organs causes lymphoproliferative disease in EBV-seronegative recipients [J].
Haque, T ;
Thomas, JA ;
Falk, KI ;
Parratt, R ;
Hunt, BJ ;
Yacoub, M ;
Crawford, DH .
JOURNAL OF GENERAL VIROLOGY, 1996, 77 :1169-1172
[9]   Influence of Posttransplant Lymphoproliferative Disorder on Survival in Children After Heart Transplantation [J].
Hayes, Don, Jr. ;
Breuer, Christopher K. ;
Horwitz, Edwin M. ;
Yates, Andrew R. ;
Tobias, Joseph D. ;
Shinoka, Toshiharu .
PEDIATRIC CARDIOLOGY, 2015, 36 (08) :1748-1753
[10]   A population-based study of 135 lymphomas after solid organ transplantation: The role of Epstein-Barr virus, hepatitis C and diffuse large B-cell lymphoma subtype in clinical presentation and survival [J].
Kinch, Amelie ;
Baecklund, Eva ;
Backlin, Carin ;
Ekman, Tor ;
Molin, Daniel ;
Tufveson, Gunnar ;
Fernberg, Pia ;
Sundstrom, Christer ;
Pauksens, Karlis ;
Enblad, Gunilla .
ACTA ONCOLOGICA, 2014, 53 (05) :669-679